Chronic Lower Back Pain Market Report 2026

Chronic Lower Back Pain Market Overview

• Chronic Lower Back Pain market size has reached to $8.04 billion in 2025 • Expected to grow to $10.06 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Rising Geriatric Demographics Fuel Expansion In Chronic Lower Back Pain Market • Market Trend: Revolutionizing Chronic Back Pain Treatment With Abbott's Breakthrough In Spinal Cord Stimulation Technology • North America was the largest region in 2025.

What Is Covered Under Chronic Lower Back Pain Market?

Chronic low back pain (CLBP) refers to a pain that persists for 12 weeks or more despite the treatment of the underlying cause of acute low back pain or the initial injury. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression, and/or anxiety. The main types of chronic lower back pain are discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, muscular pain, and others. Discogenic pain refers to a form of low back pain that results from a damaged spinal disc, especially from degenerative disc disease, which happens naturally with aging. It is diagnosed with a clinical history, physical examination, imaging guidelines, and assessment of pain, and treated in various healthcare facilities such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

What Is The Chronic Lower Back Pain Market Growth Forecast?

The chronic lower back pain market size is expected to see steady growth in the next few years. It will grow to $10.06 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing demand for non-invasive therapies, growing adoption of digital therapeutics, expansion of outpatient pain management services, rising focus on personalized medicine, increased investments in chronic pain research. Major trends in the forecast period include increasing adoption of multimodal pain management approaches, rising use of minimally invasive interventions, growing integration of digital pain monitoring tools, expansion of personalized treatment pathways, enhanced focus on non-opioid therapies.

Global Chronic Lower Back Pain Market Segmentation

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain 2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain 3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users Subsegments: 1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis 2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis 3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions 4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints 5) By Radicular Pain: Sciatica, Nerve Root Compression 6) By Muscular Pain: Muscle Strain, Muscle Spasm 7) By Other Types Of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

What Is The Driver Of The Chronic Lower Back Pain Market?

A growth in the geriatric population is expected to boost the growth of the chronic lower back pain market going forward. Geriatric population refer to a population of older people with 65 years and above. In the geriatric population, age-related neurodegenerative and musculoskeletal conditions such as arthritis and osteoarthritis progress rapidly, causing weakness and painful complaints that lead to chronic back pain and reduced physical activities. For instance, in May 2024, according to the Administration for Community Living, a US-based government agency, in 2022, 17.3% of the population was 65 or older. This percentage is expected to increase to 22% by 2040. Therefore, the growth in the geriatric population is driving the growth of the chronic lower back pain industry.

Key Players In The Global Chronic Lower Back Pain Market

Major companies operating in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy's Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Global Chronic Lower Back Pain Market Trends and Insights

Major companies operating in the chronic lower back pain market are developing products with advanced technologies such as BurstDR SCS technology to offer new options for patients. BurstDR SCS technology is a proprietary spinal cord stimulation (SCS) therapy that works by using mild electrical pulses to change pain signals as they travel from the spinal cord to the brain. For instance, in May 2023, Abbott Laboratories, a US-based medical device company received FDA approval for its Spinal Cord Stimulation (SCS) devices including the Proclaim SCS Family and Eterna SCS System for the treatment of chronic back pain. Abbott's SCS devices deliver its proprietary BurstDR stimulation waveform, a superior therapy designed to more closely mimic how pain signals travel to the brain and treat the emotional suffering related to pain, unlike traditional tonic stimulation.

What Are Latest Mergers And Acquisitions In The Chronic Lower Back Pain Market?

In November 2023, Boston Scientific, a US-based biotechnology engineering firm, acquired Relievant Medsystems, Inc. for $850 million. This acquisition enhances Boston Scientific's portfolio in chronic pain management by incorporating Relievant's intracept intraosseous nerve ablation system, which is specifically designed to treat vertebrogenic pain, a type of chronic lower back pain. Relievant Medsystems Inc. is a US-based medical equipment manufacturing company.

Regional Outlook

North America was the largest region in the chronic lower back pain market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Lower Back Pain Market?

The chronic low back pain market includes revenues earned by entities by providing low back pain treatment services such as pain management services, and neuropathic and nociceptive pain management. Establishments that provide long treatment plans and management services are included in this market. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Lower Back Pain Market Report 2026?

The chronic lower back pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic lower back pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.